Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Clinical Microbiology Reviews|July 17, 2007
Carbapenemases: the versatile beta-lactamasesAnne Marie Queenan, Karen Bush
Antimicrobial Agents and Chemotherapy|March 30, 2006
Novel carbapenem-hydrolyzing oxacillinase OXA-62 from Pandoraea pnomenusaInes Schneider, Anne Marie Queenan, Adolf Bauernfeind
Antimicrobial Agents and Chemotherapy|November 4, 2009
Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenemAnne Marie Queenan, Wenchi Shang, Robert Flamm, et al.
Antimicrobial Agents and Chemotherapy|July 8, 2010
Differential selection of single-step AmpC or efflux mutants of Pseudomonas aeruginosa by using cefepime, ceftazidime, or ceftobiproleAnne Marie Queenan, Wenchi Shang, Karen Bush, et al.
Journal of Chemotherapy (Florence, Italy)|June 21, 2013
Assessment of the combination of doripenem plus a fluoroquinolone against non-susceptible Acinetobacter baumannii isolates from nosocomial pneumonia patientsAnne Marie Queenan, Todd A Davies, Wenping He, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2009
New variant of CTX-M-type extended-spectrum beta-lactamases, CTX-M-71, with a Gly238Cys substitution in a Klebsiella pneumoniae isolate from BulgariaInes Schneider, Anne Marie Queenan, Rumyana Markovska, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2007
Interactions of ceftobiprole with beta-lactamases from molecular classes A to DAnne Marie Queenan, Wenchi Shang, Malgosia Kania, et al.
Antimicrobial Agents and Chemotherapy|June 4, 2008
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and GermanyInes Schneider, Emma Keuleyan, Rudolf Rasshofer, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2003
Biochemical characterization of beta-lactamases Bla1 and Bla2 from Bacillus anthracisIsabel C Materon, Anne Marie Queenan, Theresa M Koehler, et al.
Pageof 3